Covington Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Covington Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$22K	Hold	750	–	–	﹤0.01%	697
2022 Q2	$27K	Hold	750	–	–	﹤0.01%	663
2022 Q1	$32K	Hold	750	–	–	﹤0.01%	649
2021 Q4	$38K	Hold	750	–	–	﹤0.01%	582
2021 Q3	$48K	Hold	750	–	–	﹤0.01%	555
2021 Q2	$54K	Hold	750	–	–	﹤0.01%	532
2021 Q1	$55K	Hold	750	–	–	﹤0.01%	470
2020 Q4	$55K	Hold	750	–	–	﹤0.01%	456
2020 Q3	$41K	Hold	750	–	–	﹤0.01%	461
2020 Q2	$50K	Hold	750	–	–	﹤0.01%	441
2020 Q1	$46K	Hold	750	–	–	﹤0.01%	428
2019 Q4	$66K	Hold	750	–	–	﹤0.01%	429
2019 Q3	$57K	Hold	750	–	–	﹤0.01%	428
2019 Q2	$64K	Hold	750	–	–	﹤0.01%	403
2019 Q1	$81K	Hold	750	–	–	0.01%	361
2018 Q4	$63K	Hold	750	–	–	﹤0.01%	391
2018 Q3	$74K	Hold	750	–	–	﹤0.01%	365
2018 Q2	$87K	Hold	750	–	–	0.01%	350
2018 Q1	$74K	Hold	750	–	–	﹤0.01%	376
2017 Q4	$79K	Hold	750	–	–	﹤0.01%	389
2017 Q3	$85K	Buy	+750	New	+$81.6K	0.01%	363

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Covington Capital Management's TARO Position: Q3 2022 in Review

Covington Capital Management held its Taro Pharmaceutical Industries Ltd. (TARO) position steady in Q3 2022 at 750 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Covington Capital Management first reported a position in TARO in Q3 2017 and has held it in 21 quarters since. The position peaked at $87K in Q2 2018. 71 funds tracked by Wall St. Rank hold TARO as of Q3 2022.

Covington Capital Management held 750 shares of Taro Pharmaceutical Industries Ltd. worth $22K as of Q3 2022.
Covington Capital Management left its Taro Pharmaceutical Industries Ltd. share count unchanged in Q3 2022.
Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #697 holding.
Covington Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2017 and has held it in 21 quarters since.
Covington Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $87K in Q2 2018.
71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.